Approval · Notice of Compliance 7730 · 2006
DIGOXIN INJECTION C.S.D.: Notice of Compliance 7730
Issued February 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7730
- Date
- February 2, 2006
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Cardiotonic glycoside
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIGOXIN INJECTION C.S.D. | 02048264 | Marketed |
Medicinal ingredients
- DIGOXIN 0.25 MG per ML